Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in VIR — Vir Biotechnology, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,368,089
+$555,122 QoQ
Shares Held
134,258
+48.0% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 237 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. VIR ranks #131 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in VIR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,368,089 134,258
2026-03-31 $812,967 90,733
2025-12-31 $1,243,518 206,222
2025-09-30 $1,159,723 203,104
2025-06-30 $985,294 195,495
2025-03-31 $1,349,719 208,290
2024-12-31 $1,590,827 216,734
2024-09-30 $1,417,250 189,219
2024-06-30 $409,729 46,037
2024-03-31 $420,039 41,465
2023-12-31 $417,097 41,461
2023-09-30 $397,999 42,476
2023-06-30 $913,913 37,257
2023-03-31 $2,657,595 114,207
2022-12-31 $3,621,531 143,087
2022-09-30 $759,535 39,395
2022-06-30 $1,101,322 43,240
2022-03-31 $1,143,973 44,478
2021-12-31 $2,019,221 48,226
2021-09-30 $2,171,733 49,902
2021-06-30 $2,228,777 47,140
2021-03-31 $2,144,623 41,830
2020-12-31 $1,224,595 45,728
2020-09-30 $1,057,466 30,803
2020-06-30 $958,410 23,393
2020-03-31 $85,365 2,491